Floracene
Optimized medical device purchasing for independent providers
Floracene operates in healthcare based in New York City, NY, USA.
Profile
Floracene shows independent surgery centers the best-priced equivalent implant for every procedure based on their manufacturer contracts.
Every orthopedic surgeon we've talked to says the same thing: 90%+ of expensive implants they use are clinically interchangeable, but the choice comes down to habit, brand comfort, or the device rep. US surgery centers spend ~$7B a year on implants, and in orthopedic and spine cases the implant alone runs ~40-60% of the total cost of the procedure. Roughly ~20-30% of that spend is recoverable by switching to a clinically-equivalent device. Instead of defaulting to the implant they trained on, a surgeon sees the 3+ equivalent options side by side and switches to the one that protects the case's margin.
Asaph and Jonah met on the hospitals team at Palantir two years ago, and have each spent the last four years in the plumbing of US healthcare: claims, eligibility, and payor contracting. Asaph was an early PM at Garner. Jonah was a founding engineer at Metriport (YC S22) after starting his own fax-automation startup for fertility clinics.
At a big hospital the surgeon picks the implant but isn't spending their own money, so price doesn't impact the decision. At an independent surgery center the physicians own the economics, so a cheaper equivalent goes straight to their bottom line. They have every incentive to switch. They just don't
Floracene is positioned in healthcare, a segment that rewards a clear, focused offering.
Its base of operations is New York City, NY, USA.
Its current recorded stage is Summer 2026.
The company reports a headcount in the 2 range.
Directory analysis
Floracene provides a platform that helps independent surgery centers identify the best‑priced equivalent implants for each procedure based on existing manufacturer contracts. By presenting surgeons with clinically interchangeable options side by side, the service aims to reduce implant costs and protect surgical margins. The company focuses on orthopedic and spine cases, where implant costs represent a significant portion of total procedure expenses.
Positioning: Floracene operates in the healthcare supply chain niche, targeting small to mid‑size surgery centers that seek cost efficiencies without compromising clinical outcomes. Its value proposition centers on data‑driven purchasing decisions and contract optimization within the implant market.
Note: Floracene helps independent surgery centers lower implant costs by offering clinically equivalent alternatives.
Auto-generated directory analysis from public data · updated 6 Oct 2026. Informational only, not investment advice.
| Sector | Healthcare |
|---|---|
| Headquarters | New York City, NY, USA |
| Country | USA |
| Employees | 2 |
| Stage | Summer 2026 |
Website: www.floracene.com
Browse related
Create a free account